Your activity: 174 p.v.
Why UpToDate?
What's New
Patient Education
Calculators
Drug interactions
Subscribe
Log In
< Back
Acneiform eruption secondary to epidermal growth factor receptor (EGFR) and MEK inhibitors
Acute generalized exanthematous pustulosis (AGEP)
Cutaneous adverse effects of conventional chemotherapy agents
Cutaneous adverse events of molecularly targeted therapy and other biologic agents used for cancer therapy
Drug eruptions
Drug reaction with eosinophilia and systemic symptoms (DRESS)
Exanthematous (maculopapular) drug eruption
Fixed drug eruption
Hand-foot skin reaction induced by multitargeted tyrosine kinase inhibitors
Lichenoid drug eruption (drug-induced lichen planus)
Mucocutaneous toxicities associated with immune checkpoint inhibitors
Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae
Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis
